CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-19 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −1,101 | $0.47 | $517 | 263,846 |
| 2026-07-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −3,874 | 23,246 | ||
| 2026-06-16 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +12,500 | 264,628 | ||
| 2026-06-16 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −3,555 | $0.38 | $1K | 261,073 |
| 2026-06-16 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −12,500 | 12,500 | ||
| 2026-06-06 | Forbes William P EVP, Chief Development Officer | Option exercise | +12,500 | 221,611 | ||
| 2026-06-06 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −12,500 | 12,500 | ||
| 2026-05-06 | Hensley Mark Earl Chief Operating Officer | Option exercise | +125,000 | 136,770 | ||
| 2026-05-06 | Hensley Mark Earl Chief Operating Officer | Option exercise · Restricted Stock Units | −125,000 | 375,000 | ||
| 2026-04-30 | Hensley Mark Earl Chief Operating Officer | Option exercise | +11,770 | 11,770 | ||
| 2026-04-30 | Hensley Mark Earl Chief Operating Officer | Option exercise · Restricted Stock Units | −11,770 | 176,545 | ||
| 2026-04-30 | Forbes William P EVP, Chief Development Officer | Option exercise | +11,694 | 197,341 | ||
| 2026-04-30 | Forbes William P EVP, Chief Development Officer | Option exercise | +11,770 | 209,111 | ||
| 2026-04-30 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −11,694 | 128,638 | ||
| 2026-04-30 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −11,770 | 176,545 | ||
| 2026-04-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +11,694 | 227,570 | ||
| 2026-04-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +13,535 | 252,128 | ||
| 2026-04-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −11,694 | 128,638 | ||
| 2026-04-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −13,535 | 203,027 | ||
| 2026-04-30 | Collard Craig A Chief Executive Officer | Option exercise | +34,789 | 696,841 |
Page 4 of 28 · 557 trades